Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 733, pseudogene (RNU6-733P)
- Target
- RNU6-733P
- Molecular classification
- Other (non-coding RNA pseudogene), Pseudogene, Small nuclear RNA (snRNA)-derived
01
Overview
RNA, U6 small nuclear 733, pseudogene (RNU6-733P) is a processed pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNAs play an essential role as components of the spliceosome, catalyzing pre-mRNA splicing in the nucleus[1][5]. Pseudogenes such as RNU6-733P are generally non-functional remnants resulting from gene duplication or retrotransposition, and do not encode active proteins or RNAs. Some pseudogenes can act as regulators by acting as miRNA sponges or by influencing gene expression through other mechanisms, but there is no specific evidence that RNU6-733P is involved in such regulatory or disease processes[2]. RNU6-733P is not considered a therapeutic target or receptor, and it is not associated with any approved drugs, disease involvement, or clinical biomarker use.
- Other names
- RNU6-733PRNA, U6 small nuclear 733, pseudogene
02
Mechanism of action
Not applicable; there are no drugs or therapies targeting RNU6-733P.
03
Biological functions
None established for pseudogenes; parental gene (U6 snRNA) is involved in RNA splicing within the spliceosome[1][5].U6 snRNA functions in catalyzing intron excision during mRNA splicing[1][5].Pseudogenes may have regulatory functions (e.g., miRNA sponges), but this is not specifically reported for RNU6-733P[2].
04
Disease associations
None established for RNU6-733P.Some pseudogenes have been implicated in cancer and other diseases primarily through regulatory mechanisms[2].No evidence links RNU6-733P specifically to any disease.
05
Safety considerations
None noted.Pseudogenes usually do not pose therapeutic safety concerns, though insertional mutagenesis or regulatory effects are possible in rare cases[2].
06
Interacting drugs
None known.
1 more in the full profile.
07
Biomarkers
None established for RNU6-733P.Some pseudogenes can act as disease biomarkers, but this is not indicated for RNU6-733P[2].
Beyond the preview
Go deeper on RNA, U6 small nuclear 733, pseudogene (RNU6-733P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 733, pseudogene (RNU6-733P).